148 related articles for article (PubMed ID: 36648988)
1. Predicting Underestimation of Invasive Cancer in Patients with Core-Needle-Biopsy-Diagnosed Ductal Carcinoma In Situ Using Deep Learning Algorithms.
Do LN; Lee HJ; Im C; Park JH; Lim HS; Park I
Tomography; 2022 Dec; 9(1):1-11. PubMed ID: 36648988
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
J Am Coll Radiol; 2018 Mar; 15(3 Pt B):527-534. PubMed ID: 29398498
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
Shin HJ; Choi WJ; Park SY; Ahn SH; Son BH; Chung IY; Lee JW; Ko BS; Kim JS; Chae EY; Cha JH; Kim HH
Clin Breast Cancer; 2022 Apr; 22(3):e374-e386. PubMed ID: 34776365
[TBL] [Abstract][Full Text] [Related]
4. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
[TBL] [Abstract][Full Text] [Related]
5. Deep learning analysis of breast MRIs for prediction of occult invasive disease in ductal carcinoma in situ.
Zhu Z; Harowicz M; Zhang J; Saha A; Grimm LJ; Hwang ES; Mazurowski MA
Comput Biol Med; 2019 Dec; 115():103498. PubMed ID: 31698241
[TBL] [Abstract][Full Text] [Related]
6. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
7. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
[TBL] [Abstract][Full Text] [Related]
8. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
10. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
Shigematsu H; Kadoya T; Masumoto N; Matsuura K; Emi A; Kajitani K; Amioka A; Okada M
Clin Breast Cancer; 2014 Oct; 14(5):358-64. PubMed ID: 24962555
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the histologic upgrade of ductal carcinoma
Lee HJ; Park JH; Nguyen AT; Do LN; Park MH; Lee JS; Park I; Lim HS
Front Oncol; 2022; 12():1032809. PubMed ID: 36408141
[TBL] [Abstract][Full Text] [Related]
12. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
Harowicz MR; Saha A; Grimm LJ; Marcom PK; Marks JR; Hwang ES; Mazurowski MA
J Magn Reson Imaging; 2017 Nov; 46(5):1332-1340. PubMed ID: 28181348
[TBL] [Abstract][Full Text] [Related]
13. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
14. A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
Park HS; Kim HY; Park S; Kim EK; Kim SI; Park BW
Breast; 2013 Oct; 22(5):869-73. PubMed ID: 23601760
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ: Is core needle biopsy ever enough?
Caswell-Smith P; Wall M
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):29-33. PubMed ID: 27554420
[TBL] [Abstract][Full Text] [Related]
16. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
17. Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
Kim MY; Yoen H; Ji H; Park SJ; Kim SM; Han W; Cho N
Korean J Radiol; 2023 Dec; 24(12):1190-1199. PubMed ID: 38016679
[TBL] [Abstract][Full Text] [Related]
18. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
20. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature.
Dória MT; Maesaka JY; Soares de Azevedo Neto R; de Barros N; Baracat EC; Filassi JR
Clin Breast Cancer; 2018 Oct; 18(5):e805-e812. PubMed ID: 29798815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
